Healthcare device

Abstract

Healthcare device, featuring: a low-frequency wave transmitter (2); a carrier (A) for essential oils; and a low-frequency waveguide, wherein the carrier (A) for essential oils is arranged between the low-frequency wave transmitter (2) and the low-frequency waveguide; wherein the low-frequency wave transmitter (2) can emit a low-frequency wave (W) of a predetermined frequency; and wherein the low-frequency wave (W) can be transferred to the low-frequency waveguide after passing through the carrier (A) for essential oils, and wherein the energy of the low-frequency wave (W) can be concentrated and radiated onto the low-frequency waveguide.

Description

[0001] The invention relates to a healthcare device and a healthcare method, in particular to a healthcare device and a healthcare method in which a low-frequency wave is passed through a carrier for essential oils and then transmitted to the human body for the purpose of personal care.

[0002] Currently known health care methods include scraping, cupping, acupuncture, massage, and others. Although they can play a role in maintaining and promoting health, they also have shortcomings. For example, scraping can damage the skin and increase the risk of infection. The effect of cupping is similar to that of scraping, but the use of suction cups requires skin contact, so the cleanliness and hygiene of the suction cups is a concern. Acupuncture uses needles that penetrate the corresponding acupuncture points on the human body, so there is an invasive risk. Massage, although non-invasive, requires a person to relax the patient's muscles.

[0003] To improve the above-mentioned acupuncture therapy method, a microwave acupuncture device is known, which non-invasively irradiates acupuncture points on the human body. The microwave oscillator used in the microwave acupuncture device has an oscillation frequency of up to 1000-2000 megahertz (MHz), which can easily cause damage due to excessive radiation (energy). In fact, when using the microwave acupuncture device, it is also necessary to find the corresponding acupuncture points on the human body for treatment. However, ordinary people are not experts in traditional Chinese medicine and cannot accurately identify each acupuncture point, so the microwave acupuncture device is not actually a healthcare device that can be widely used.

[0004] Therefore, it is a trend in the industry to develop a healthcare device and method that is easy to use, can accurately identify usage positions, and can avoid the problem of excessive energy caused by the high-frequency microwave oscillator.

[0005] The present invention is primarily based on the recognition that the major tissues and organs of the human body (referring to organisms, not artificial tissues or organs) have natural vibration frequencies, such as 8 to 12 Hz for the head, 4 to 6 Hz for the thoracic cavity, 5 Hz for the heart, 6 to 9 Hz for the thoracic cavity, 1.2 Hz for the blood flow frequency, and 1.8 Hz for bone tissue. When a certain part of the human body is in the low-frequency wave field of 0 to 20 Hz, such as low-frequency waves or infrasound waves, also called ultrasonic waves or ultrasonic waves above 20 kHz, and when the sound pressure level [sound pressure level, unit: dB] reaches a certain threshold, the elastic wall of the outer layer of the tissue and organ corresponding to that part first enters the vibration state. Then, the vibration is transmitted to the interior of the tissue and organ.Resonance occurs especially when the frequency of the low-frequency wave is synchronized with the aforementioned natural vibration frequency of the tissues and organs. In this case, the tissues and organs receive the greatest stimulation at this time. When the resonance caused by the low-frequency wave acts on the tissues and organs, it also affects the cellular structures of the tissues and organs, such as the mitochondria of the cells. Mitochondria are the main sites for oxidative phosphorylation and the synthesis of adenosine triphosphate (ATP) in cells, thus providing chemical energy for cellular activities. Therefore, they are called the "powerhouses of the cell."

[0006] ATP enters the membrane potential of the cell membrane (membrane potential, transmembrane potential, or membrane voltage). The cell membrane is a thin film composed of a phospholipid bilayer (lipid bilayer or phospholipid bilayer). The cell membranes of almost all cellular organisms consist primarily of phospholipid bilayers. The interior of the phospholipid bilayer is filled with dielectrics, so that the cell membrane formed by the phospholipid bilayer is electrically equivalent to a capacitor. The structure of the cell membrane includes not only the phospholipid bilayer but also proteins, some of which act as ion channels, allowing ions (such as positively charged sodium ions Na+ and potassium ions K+) to be transported across the cell membrane. This phenomenon is physically understandable.This means that the cell membrane acting as a capacitor is a leakage capacitor, with the leakage current (ion transport) flowing through the capacitor.

[0007] The resonance effect of the aforementioned low-frequency wave also influences the action of adenosine monophosphate-activated protein kinase (AMPK). Regarding the relationship between low-frequency vibrations and AMPK, one can refer to "Low-frequency vibration promotes AMPK-mediated glucose uptake in 3T3-L1 adipocytes, D. Haba et al., Volume 7, Issue 9, September 2021." Activated AMPK leads to an increase in nicotinamide phosphoribosyltransferase (NAMPT) and thus also the level of nicotinamide adenine dinucleotide (NAD). + ) increases. The above-mentioned correlation can be found in "AMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscle, J. Brandauer et al., J Physiol. 2013 Oct 15; 591 (Pt 20): 5207-5220." In addition, NAD +a key molecule in the synthesis of ATP, so an increase in NAD + -content can also lead to an increase in ATP content.

[0008] In addition, the resonance effect exerted on the mitochondria by the above-mentioned low-frequency waves will also affect the binding state of some enzymes, such as ATPase, at the cell membrane and the activity of the enzyme. ATPase is an enzyme that can break down ATP to generate energy and can activate Na+ and K+. Therefore, it is also called Na + -K + -ATPase or Na + -K + -pump). The Na + -K + -pump can regulate the concentration of sodium ions and potassium ions inside and outside the cell membrane. This means that the membrane potential of the cell membrane is determined by the Na + -K +-pump adaptable. For example, the return of the membrane potential of the cell membrane from the action potential to the resting potential occurs. Initially, the cell membrane is at the resting potential. If the cell membrane is properly stimulated in the resting potential state, an action potential is generated, which normally goes through the following phases sequentially: polarization, depolarization, repolarization, and overpolarization. Especially during the overpolarization phase, the action potential is lower than the resting potential. At this time, the Na + -K +The action potential pump causes the membrane potential of the cell membrane to return from the action potential to the resting membrane potential during the overpolarization phase. Therefore, it is understandable that long-term exposure to stimuli (such as stress), long-term human inflammation, or long-term deficiency of ATP and / or ATPase will cause cells to remain in the overpolarization phase for a long time, with the membrane potential of the cell membrane lower than the resting potential.

[0009] Based on the above-mentioned understanding that the cell membrane is electrically equivalent to a capacitor (or a battery), the membrane potential of the cell membrane is equivalent to the battery's voltage. The action potential is lower than the resting potential during the above-mentioned overpolarization phase. The action potential of the cell membrane in the overpolarization phase can be understood as the residual power (voltage) after the battery is depleted (after use). The resting potential can then be understood as the initial power (voltage) that is either not dissipated or recharged. According to statistics, there are an average of 37.2 trillion cells in the human body, thus an average of 37.2 trillion "batteries" in the human body. It can be understood that when the body is chronically stressed or inflamed, the cells are correspondingly chronically hyperpolarized and thus in a state of "battery depletion."As a result, cells cannot perform or maintain their proper functions. The tissues and organs of the human body also appear sick or fatigued. At this time, when a low-frequency wave of a certain intensity and / or frequency acts on cells, the energy of the wave can be converted into thermal energy, biochemical energy, and bioelectrical energy, thereby increasing the activity of ATPase. At the same time, ATPase can cause the membrane potential of the cell membrane to return from the action potential to the resting potential during the overpolarization phase. This causes the aforementioned "battery," corresponding to human cells, to return from the state of "battery depletion" during the aforementioned overpolarization phase to the initial charge (voltage) or full charge.In other words, low-frequency waves can "recharge" cells in the hyperpolarization phase, so that the use of low-frequency waves to act on tissues and organs can repair damaged tissues, and normal functions can be restored under the stimulation of low-frequency waves. There is an example of the relationship between low-frequency waves and living organisms: For example, the frequency of the Schumann resonance in the extremely low frequency (ELF) low-frequency wave is 7.83 Hz, which is exactly the same frequency as that of the hippocampus of the mammalian brain. In particular, the alpha and theta waves of the human brain are also close to 8 Hz. Therefore, the U.S. National Aeronautics and Space Administration (NASA) installed a Schumann wave generator in the manned space capsule to maintain the physical and mental health of astronauts in space.For the increase of ATPase activity by low frequency waves, reference can be made to "Effects of low frequency magnetic fields on Na,K-ATPase activity", M. Blank, L. Soo, V. Papstein, Bioelectrochemistry and Bioenergetics 38 (1995) 267- 273". The use of 0-70 Hz low frequency waves (magnetic waves) can increase the activity of Na. + -K + -ATPase by 5-10%. In other words, low-frequency waves can activate cells and "charge" cells in the hyperpolarization phase. Therefore, low-frequency waves can be used in the "cell activation technique." It should be noted here that low-frequency waves can also include electromagnetic waves such as electric waves, magnetic waves, or light waves, or low-frequency waves.

[0010] Therefore, it can be concluded that the aforementioned low-frequency waves trigger an increase in the amount and / or activity of ATP and / or ATPase. ATPase hydrolyzes ATP and generates energy. This allows helicases to unravel the double helix structure of deoxyribonucleic acid (DNA), thus assisting DNA polymerase in DNA replication. This not only promotes cell division but also enables the repair of damaged genes.

[0011] According to traditional Chinese medicine theory, the human navel is the Shenque acupuncture point, where the Ren, Du, Dai, and Chong pulses pass through. Therefore, when the Shenque acupuncture point is stimulated, the entire body can be adjusted by connecting the internal organs through the meridians. In addition, according to Western medicine theory, the navel is the thinnest part of the epidermal cuticle in the human abdomen, and there is no fatty tissue below the navel, so its barrier function is the weakest. In addition, the skin of the navel also has a rich venous network and inferior abdominal artery branches in addition to the microcirculation blood vessels of the general skin. Therefore, as long as a certain effect or change is exerted on the blood in the microcirculation blood vessels of the umbilical skin, this effect or change can be brought into the human bloodstream.Furthermore, the position of the human navel is easy to identify and does not vary depending on the person's height, weight, and thinness. Using the navel as the corresponding position where the healthcare device emits the low-frequency wave is beneficial for the user to accurately identify the usage position.

[0012] The present invention also recognizes that a low-frequency wave transmitter capable of generating low-frequency waves (such as low-frequency electric waves, low-frequency magnetic waves, and low-frequency sound waves) can be used in a manner that does not directly contact the navel. The low-frequency wave transmitter emits low-frequency waves toward the navel to achieve an effect similar to acupuncture. This can achieve a non-invasive, non-contact healthcare effect. Preferably, a bass wave transmitter capable of generating the bass wave does not contact the navel, so the bass wave transmitter emits the bass wave toward the navel to achieve an effect similar to acupuncture. This can achieve a non-invasive, non-contact healthcare effect.In particular, the bass waves, low-frequency sound waves, and low-frequency waves referred to in the present invention have the same meaning. When the bass wave is directly used as a component of the healthcare device, the problem of excessive energy caused by the high-frequency microwave oscillator can be avoided. At the same time, the adverse effects of electric waves or magnetic waves on some people with special constitutions can also be avoided. Therefore, the above-mentioned effect of the present invention, which is similar to acupuncture, can also be called "moxa acupuncture."

[0013] Bass waves can achieve effects similar to those of acupuncture (or moxibustion). In addition, acupuncture's effect on the immune system is that it can increase the levels of interferon-gamma (γ-IFN) and neuropeptide beta-endorphin, which can activate natural killer cells (NK cells). Natural killer cells also secrete cytokines, which can therefore regulate the inflammatory response. NK cells are lymphocytes with large granules in the cytoplasm and are therefore considered immune cells. They develop from lymphoid stem cells of the bone marrow and are distributed primarily in the peripheral blood (including blood in microcirculatory blood vessels) and the spleen, but also in small numbers in lymph nodes and other tissues.

[0014] As mentioned above, the navel is the thinnest part of the epidermal cuticle in the human abdomen, and there is no fatty tissue below the navel, so its barrier function is the weakest. In addition to the microcirculation blood vessels of the general skin, the navel skin also has a rich venous network and inferior abdominal artery branches. Therefore, as long as a certain effect or change is exerted on the blood in the microcirculation blood vessels of the umbilical skin, this effect or change can be introduced into the human blood circulation system. Therefore, when the bass wave is emitted toward the navel, it triggers an acupuncture-like effect, so that the levels of γ-IFN and β-endorphins in the blood in the microcirculation blood vessels of the umbilical skin increase, activating NK cells, B cells (B cells, B lymphocytes), and active T cells (or active T lymphocytes).Because NK cells, B cells, and active T cells secrete cytokines, they can regulate inflammation or secrete antibodies. One way to increase endorphin levels in the brain is to apply the aforementioned bass wave to a container filled with essential oil, causing the oil in the container to move (see US Patent US6063894A or European Patent EP3970507A1). This accelerates the exhalation of oil molecules and transmits them via the olfactory nerve to the brain's limbic system, which can increase the release of endorphins and activate NK cells, B cells, and activated T cells. Furthermore, essential oils are synthesized through photosynthesis in the cells near the glands of plants. Therefore, most plant leaves contain essential oils, and the essential oil produced in the leaves passes through the cell walls into the glands and is stored in other parts of the plant.Therefore, the effect of the aforementioned bass wave on plants causes the essential oil stored in the plant to be released into the air (see US Patent US3491022A on the effect of low-frequency waves on reverse osmosis). This oil is then transmitted via the olfactory nerve to the limbic system of the brain, which increases the release of endorphins and activates NK cells, B cells, and activated T cells. When the aforementioned bass wave acts on leaves and other parts of plants with sufficient moisture, it can also cause the double helix structure of DNA to break down, as previously mentioned.

[0015] Furthermore, the present invention recognizes that NAD +and / or essential oils can have a protective effect on telomeres. Regarding the connection between essential oils and telomere length, reference can be made to the study "Effects of Essential Oils on Telomere Length in Human Cells, Plant J, Plant, Med Aromat Plants 2016, 5:2." Regarding the connection between NAD + and telomere length, reference can be made to the study “NAD-Linked Metabolism and Intervention in Short Telomere Syndromes and Murine Models of Telomere Dysfunction, Amanda J Stock and Yie Liu, Front Aging. 2021; 2: 785171”.

[0016] When the bass wave transmitter is used to emit bass waves towards the navel, the navel + -K +The ATPase activity of activated T cells in the blood vessels of the umbilical microcirculation can be increased. This can increase the activity of activated T cells. In other words, when the bass wave transmitter is used to emit bass waves toward the navel, the activated T cells with low activity can be "recharged" to restore their activity, so that the activated T cells that have been "recharged" can be verified. Therefore, as long as the changes in the content of NK cells, B cells, or activated T cells in the blood are detected, the effectiveness of the healthcare device according to the invention can be verified. Of course, the ability of NK cell lines to kill cancer cell lines (K562) can also be utilized.For example, the ability can be measured in samples cultured in a mixture of NK cell to target cell ratio (Effector to Target Cell Ratio, E / T ratio), and the results can be compared to verify the feasibility of the healthcare device / healthcare method of the invention.

[0017] Furthermore, based on the fact that the low frequency wave leads to an increase of NAD + and an increase in ATP, as well as an increase in the amount and / or activity of ATP and / or ATPase, which in turn enables the unfolding of the DNA double helix and contributes to cell division, the effectiveness of the present healthcare device can be assessed by measuring the changes in the levels of NAD + , NK cells, B cells or activated T cells can be detected in the blood.

[0018] According to the invention, a healthcare device is provided comprising: a low-frequency wave transmitter; a carrier for essential oils; and a low-frequency waveguide, wherein the carrier for essential oils is arranged between the low-frequency wave transmitter and the low-frequency waveguide, wherein the low-frequency wave transmitter can radiate a low-frequency wave of a predetermined frequency; wherein the low-frequency wave can be transferred to the low-frequency waveguide after passing through the carrier for essential oils, and wherein the energy of the low-frequency wave can be radiated in a concentrated manner onto the low-frequency waveguide.

[0019] According to the invention, the carrier for essential oils contains an essential oil.

[0020] According to the invention, the carrier for essential oils is selected from a group comprising a part of the plant containing the essential oil, a container in which the essential oil is stored, and an adsorbent material on which the essential oil is adsorbed.

[0021] According to the invention, the predetermined frequency is in the range of 1.27 to 1.81 Hz.

[0022] According to the invention, the low-frequency waveguide comprises a cylinder and / or a cone provided with a receiving space in which the carrier for essential oils is located.

[0023] According to the invention, the healthcare device is mounted on a support bracket and is located in a predetermined position in front of the navel of a user, wherein there is a predetermined distance between the healthcare device and the navel, which distance is in the range of 5 to 8 centimeters.

[0024] According to the invention, the low-frequency waveguide is located at the predetermined position.

[0025] According to the invention, after the energy of the low-frequency wave is concentrated in the low-frequency waveguide, it is radiated toward the navel and finally reaches the navel.

[0026] According to the invention, there is provided a healthcare method in which a healthcare device as mentioned above is arranged in front of a navel of a user and forms a predetermined distance from the navel at a predetermined position, the healthcare device emitting a low frequency wave of a predetermined frequency toward the navel.

[0027] According to the invention, the predetermined frequency is 1.45 Hz.

[0028] Therefore, the healthcare device and method according to the invention achieves convenient handling, precise detection of the application position, and health-promoting effects that are non-invasive, non-contact, and without unnecessary energy hazards or risks of injury.

[0029] The invention and its embodiments are explained in more detail below with reference to the drawing. The drawing shows: Fig. 1 is a schematic representation of the implementation of the healthcare method according to the invention; Fig. 2 shows a schematic structural representation of a healthcare device according to the invention when carrying out the healthcare method according to the invention; Fig. 3 is a perspective structural view of the healthcare device according to the invention; Fig. 4 is a perspective structural view of the healthcare device according to the invention with a pipeline; Fig.5 is a perspective structural view of the healthcare device according to the invention with an upright rod; Fig. 6 is a perspective structural view of the healthcare device according to the invention mounted on a storage bracket; and Fig. 7 is a perspective structural view of the healthcare device according to the present invention, the low frequency wave transmitter of which is mounted on the cone bottom surface of the cone.

[0030] The present invention will be described in detail below using a specific embodiment. It should be noted, however, that components of the present invention mentioned in this embodiment are not described precisely in terms of their scale, dimensions, variables, and displacement paths, but are only shown schematically, with similar components always being designated by the same numbers.

[0031] In Fig.1 shows a healthcare method according to the present invention. A low-frequency wave W of a predetermined frequency is radiated from a low-frequency wave transmitter 2 at a predetermined position P in front of a navel 11 of a user 1 toward the navel 11, the navel 11 being separated from the predetermined position P by a predetermined distance D. The aforementioned "in front" refers to the front of the human body, as opposed to "behind," which refers to the back of the human body. The predetermined position P is located on a virtual bottom surface S2 of a virtual cone S having the navel 11 as the virtual apex S1, such that the predetermined distance D is not greater than 8 cm, the predetermined distance D is not less than 5 cm, or the predetermined distance D is in the range of 5 to 8 cm.Preferably, the predetermined position P is located in the center of the virtual ground surface S2. For example, the virtual cone S is conical, with the predetermined position P located at the circular center of the circular, virtual ground surface S2. Furthermore, the predetermined distance D is the distance between the circular center and the navel 11, which is between 5 and 8 cm. An essential oil carrier A containing an essential oil is placed between the predetermined position P and the virtual tip S1. The essential oil refers to an oily substance stored in plants or extracted from plants and is highly volatile at room temperature. The essential oil carrier A can therefore be a part of the plant containing the essential oil, such as roots, stems, leaves, flowers, fruits, and seeds, such as the leaves of Plectranthus amboinicus.The carrier A for essential oils according to the invention may also be a container containing various essential oils obtained from plants by known distillation or extraction methods, or, for example, cotton or paper, which are an adsorbent material. Examples of essential oils are tea tree oil, karanja oil, Plectranthus amboinicus oil, lemon oil, holly, camphor oil, clove oil, peppermint oil, blue gum eucalyptus oil, lemongrass oil, allspice oil, sage oil, lemon eucalyptus oil, rose oil, jasmine oil, geranium oil, rose geranium oil, ylang-ylang oil, frankincense oil, patchouli oil, rosemary oil, immortelle oil, thyme oil, pine oil, cedarwood oil, juniper oil, sandalwood oil, basil oil, lime oil, orange oil, sweet orange oil, bitter orange oil, bitter orange leaf oil, orange blossom oil, bergamot oil, comfrey oil, yarrow oil or ginger oil.The low-frequency wave W emitted by the low-frequency wave transmitter 2, which is directed toward the navel 11, first penetrates the essential oil carrier A and then reaches the navel 11.

[0032] The low-frequency wave transmitter 2 is preferably a low-frequency wave transducer so that the low-frequency wave W can be a low-frequency wave. Structurally, the low-frequency wave transducer includes a power source 21 and a vibrating element 22, wherein the vibrating element 22 is electrically connected to the power source 21. The vibrating element 22 is a disc-shaped piezoelectric ceramic transducer made of a piezoelectric material polarized in the thickness direction. The power source 21 supplies electrical energy to the vibrating element 22, so that the vibrating element 22 vibrates in the thickness direction to generate the low-frequency wave of the predetermined frequency, wherein the predetermined frequency is not higher than 1.81 Hz, or the predetermined frequency is not lower than 1.27 Hz, or the predetermined frequency is between 1.27 and 1.81 Hz. Preferably, the predetermined frequency is 1.45 Hz.

[0033] In other words, the present invention also provides a healthcare device arranged at a predetermined position P in front of a navel 11 of a user 1 and forming a predetermined distance D with the navel 11, the healthcare device comprising at least one low-frequency wave transmitter (2). <Erkennungsverfahren und -wirkung>

[0034] I. The above-mentioned healthcare procedure is performed on subjects A1 and A2, with a predetermined distance D of five centimeters, a predetermined frequency of 1.45 Hz, and a low-frequency wave. Subject A1 is 74 years old, male; subject A2 is 72 years old, female. Before performing the above-mentioned healthcare procedure, blood samples were taken from subject A1 and subject A2 and sent to the medical laboratory for immunological examination to check the percentage of activated T cells. On the 19th day after performing the above-mentioned healthcare procedure for 2 hours, a blood sample was taken again from subject A1 and sent to the medical laboratory for immunological examination. On the 42nd day after performing the above-mentioned healthcare procedure for 2 hours, the same was performed again for subject A2.Blood samples were sent to the medical laboratory for immunological testing, and the percentage of activated T cells was also examined. The results are recorded in Table 1 below. The difference between Comparative Example 1 and Working Example 1 in Table 1 is that Comparative Example 1 did not use the essential oil carrier (A). Table 1 Content of activated T cells Subject A1 Subject A2 1 2 3 1 2 3 Comparison example 1 6.2% 12.8% 206.5% 5.3% 7.9% 149% Example 1 13.5% 31.7% 234.8% 8.1% 14.6% 180% 1: before implementation 2: after implementation 3: Rate of change = After implementation / Before implementation

[0035] From Table 1, in Comparative Example 1, in which no essential oil carrier A was used for subject A1, the change rate of the activated T cell content was 206.5%. In Working Example 1, in which an essential oil carrier A was used for subject A1, the change rate of the activated T cell content was 234.8%. This means that using the above-mentioned health method with essential oil carrier A results in an additional increase of the activated T cell content by 28.3%. In Comparative Example 1, in which no essential oil carrier A was used for subject A2, the change rate of the activated T cell content was 149%. In Working Example 1, in which an essential oil carrier A was used for subject A2, the change rate of the activated T cell content was 180%.This means that the use of the above-mentioned health care method with essential oil carrier A results in an additional 31% increase in the level of activated T cells. Clearly, the health care method according to the invention is very effective and can sustain long-term health benefits.

[0036] II. The above-mentioned health care procedure will be performed on subjects A3, A4, A5, and A6, with the predetermined distance D being five centimeters, the predetermined frequency being 1.45 Hz, and the low-frequency wave being a low-frequency wave. Subject A3 is 67 years old, male; subject A4 is 64 years old, male; subject A5 is 73 years old, female; and subject A6 is 47 years old, female. Before performing the above-mentioned health care procedure, a blood sample was taken from each of subjects A3, A4, A5, and A6 and submitted to a medical laboratory for immunological testing to determine NAD. + -levels. The unit for this is nanomoles per liter (nmol / L). On the 19th day after performing the above-mentioned health care procedure for 2 hours, a blood sample was taken again from subjects A3, A4, A5, and A6 and sent to a medical laboratory for immunological testing to determine the NAD+ -levels. Results were recorded in Table 2 below. Table 2 NAD + -Level (nmol / L) Subject A3 Subject A4 Subject A5 Subject A6 1 43 26 23 32 2 116 64 42 53 3 270% 246% 183% 166% 1: before implementation 2: after implementation 3: Rate of change = After implementation / Before implementation

[0037] Table 2 shows that a blood sample was taken from subjects A3, A4, A5 and A6 before and after the above-mentioned health care procedure for immunological testing in order to determine the NAD + -levels. Before the procedure, the NAD + -Level of subject A3 was 43 nmol / L, after the procedure it was 116 nmol / L, which corresponds to a change rate of 270% and an increase in NAD + -level by 160%. The situation was similar for subject A4, whose NAD +-level was 26 nmol / L before the procedure and increased to 64 nmol / L after the procedure, which corresponds to a rate of change of 246% and an increase in NAD+ level of 146%. In subject A5, the NAD + -level before the procedure was 23 nmol / L and after the procedure it was 42 nmol / L, which corresponds to a rate of change of 183% and an increase in NAD+ level of 83%. In subject A6, the NAD + -Level before the procedure was 32 nmol / L and after the procedure was 53 nmol / L, which corresponds to a rate of change of 166% and an increase in NAD + -level by 66%. Therefore, the health care procedure described here can + -levels and a single application of only 2 hours is sufficient to increase the NAD +-levels. Clearly, the health care procedure described here has an effective and long-lasting effect.

[0038] With reference to Fig. 2 and Fig.3, the present invention also provides a healthcare device 100 that can be used to perform the aforementioned healthcare method. The healthcare device 100 according to the invention comprises the aforementioned low-frequency wave transmitter 2, a cylinder 3, and a cone 4. The cylinder 3 is preferably designed as a round cylinder. The cylinder 3 has a cylinder surface 31, a cylinder bottom surface 32, and a cylinder body 33, the two ends of which are respectively connected to the cylinder surface 31 and the cylinder bottom surface 32. The cylinder body 33 has a receiving space 331 that is recessed from the cylinder bottom surface 32 toward the cylinder surface 31. The carrier A for essential oils is located inside the receiving space 331.

[0039] The cone 4 has a cone apex 40, a cone bottom surface 41, and a cone body 42, the two ends of which are each connected to the cone apex 40 and the cone bottom surface 41. The cylinder surface 31 is connected to the cone bottom surface 41, for example, by welding or screwing. Preferably, the cylinder 3 and the cone 4 are metal cylinders or metal cones. Particularly preferably, the cylinder 3 and the cone 4 are formed integrally. In other words, the cylinder surface 31, the cylinder body 33, the cone body 42, and the cone apex 40 are formed integrally. It is particularly noteworthy that the aforementioned cylinder 3 and the cone 4 together are referred to as a low-frequency waveguide.

[0040] The low-frequency wave transmitter 2 is connected to the cylinder bottom surface 32. Preferably, the low-frequency wave transmitter 2 is directly connected to the cylinder bottom surface 32. For example, the low-frequency wave transmitter 2 is welded or screwed to the cylinder bottom surface 32. Therefore, when the energy source 21 is activated, the vibration element 22 generates the low-frequency wave W of the predetermined frequency [see Fig.1]. After the low-frequency wave W is transmitted to the cylinder bottom surface 32 and passes through the essential oil carrier A, it is transmitted successively to the cone bottom surface 41 and the cone apex 40 of the cone 4 via the cylinder body 33. The cone 4 is tapered from the wider cone bottom surface 41 to the narrower cone apex 40, so that the energy of the low-frequency wave W is more concentrated when it is transmitted to the cone apex 40. When the low-frequency wave W reaches the cone apex 40, the energy of the low-frequency wave W is concentrated to its maximum, and the low-frequency wave W is radiated from the cone apex 40 toward the navel 11.Since the cone apex 40 of the cone 4 is formed as a peak, the low-frequency wave W can satisfy a condition similar to the "peak discharge" in electricity, so that the energy of the low-frequency wave W is concentrated on the cone apex 40 and radiated toward the navel 11. Note that the cone apex 40 is located at the predetermined position P.

[0041] In another embodiment according to Fig.4, the low-frequency wave transmitter 2 is connected to the cylinder bottom surface 32 and the receiving space 331 by a conduit 5. The low-frequency wave W is transmitted from the low-frequency wave transmitter 2 to the cylinder bottom surface 32 through the conduit 5, then, as described above, after passing through the essential oil carrier A, is transmitted to the cone apex 40 and radiated toward the navel 11. Through the conduit 5, the power source 21 and / or the vibration element 22 of the low-frequency wave transmitter 2 can be kept away from the human body, thereby preventing interference with an electronic device implanted in the human body.

[0042] In a further embodiment according to Fig.5, an upright rod 401 is attached to the cone tip 40, facing away from the cone bottom surface 41. The rod 401 is preferably designed as a metal rod, metal wire, or wire. The longitudinal direction of the rod 401 coincides with a normal line N of the cone bottom surface 41, passing through the center C of the cone bottom surface 41 and facing the navel 11. In this way, the energy of the low-frequency wave W can be directed more strongly, so that the energy is concentrated on a rod tip 402 of the rod 401 and released toward the navel 11. It should be noted that the rod tip 402 is located at the predetermined position P.

[0043] In yet another embodiment according to Fig.6, the healthcare device 100 is attached to a support bracket 200. A user 1 lies on a platform (not shown) with the support bracket 200 positioned on the platform and the healthcare device 100 positioned above the user's navel. This allows the user to rest properly even during healthcare.

[0044] According to another embodiment in Fig.7, the healthcare device 100 may include the above-mentioned low-frequency wave transmitter 2 and the cone 4, but without the cylinder 3. The cylinder body 42 has a receiving space 331, which is recessed from the cylinder bottom surface 41 to the cone tip 40. The carrier A for essential oils is located inside the receiving space 331. It should be noted that the cone 4 is designed as a low-frequency waveguide without the cylinder 3. The low-frequency wave transmitter 2 is attached to and connected to the cone bottom surface 41. Preferably, the low-frequency wave transmitter 2 is directly connected to the cone bottom surface 41. For example, the low-frequency wave transmitter 2 is glued, welded, or screwed to the cone bottom surface 41. Therefore, when the power source 21 is turned on, the vibration element 22 generates the low-frequency wave W of the predetermined frequency [see Fig.1]. Then, the low-frequency wave W is transmitted to the cone bottom surface 41 of the cone 4 and penetrates the essential oil carrier A. It is then transmitted to the cone apex 40. The cone 4 may be conically shaped from the wider cone bottom surface 41 to the narrower cone apex 40, so that the energy of the low-frequency wave W is more concentrated when transmitted to the cone apex 40. Preferably, the cone 4 is a one-piece wooden cone.

[0045] The invention thus relates to a healthcare device, wherein the healthcare device comprises: a low-frequency wave transmitter (2); a carrier (A) for essential oils; and a low-frequency waveguide, wherein the carrier (A) for essential oils is arranged between the low-frequency wave transmitter (2) and the low-frequency waveguide. The low-frequency wave transmitter (2) can emit a low-frequency wave (W) of a predetermined frequency. After passing through the carrier (A) for essential oils, the low-frequency wave (W) can be transmitted to the low-frequency waveguide, wherein the energy of the low-frequency wave (W) can be emitted in a concentrated manner onto the low-frequency waveguide. The healthcare device according to the invention can emit the NAD + -levels in the blood and offer convenient operation, precise determination of treatment position as well as non-invasive and contactless healthcare.

[0046] The foregoing description illustrates the embodiments of the invention and is not intended to limit the claims. All equivalent changes and modifications that can be made by one skilled in the art in accordance with the description and drawings of the invention are within the scope of the present invention. List of reference symbols 1 user 11 Belly button 2 low-frequency wave transmitters 21 Energy source 22 Vibration element 200 storage brackets 100 healthcare devices 3 cylinders 31 Cylinder surface 32 cylinder bottom surface 33 cylinder bodies 4 cones 40 cone tip 401 sticks 402 rod tip 41 Cone bottom surface 42 conical bodies 5 Pipeline A carrier for essential oils C Middle D predetermined distance N Normal line P predetermined position S virtual cone S1 virtual tip S2 virtual floor area W Low frequency wave QUOTES CONTAINED IN THE DESCRIPTION

[0000] This list of documents submitted by the applicant was generated automatically and is included solely for the convenience of the reader. This list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions. Cited patent literature

[0000] US 6063894A

[0014] EP 3970507A1

[0014] US 3491022A

[0014] Cited non-patent literature

[0000] Low-frequency vibration promotes AMPK-mediated glucose uptake in 3T3-L1 adipocytes, D. Haba et al., Volume 7, Issue 9, September 2021

[0007] AMP-activated protein kinase regulates nicotinamide phosphoribosyl transferase expression in skeletal muscle, J. Brandauer et al., J Physiol. 2013 Oct 15; 591 (Pt 20): 5207-5220

[0007] Effects of low frequency magnetic fields on Na,K-ATPase activity“, M. Blank, L. Soo, V. Papstein, Bioelectrochemistry and Bioenergetics 38 (1995) 267- 273

[0009] Effects of Essential Oils on Telomere Length in Human Cells, Plant J, Plant, Med Aromat Plants 2016, 5:2

[0015] NAD-Linked Metabolism and Intervention in Short Telomere Syndromes and Murine Models of Telomere Dysfunction, Amanda J Stock and Yie Liu, Front Aging. 2021; 2: 785171

[0015]

Claims

[1] Healthcare device, comprising: a low frequency wave transmitter (2); a carrier (A) for essential oils; and a low-frequency waveguide, wherein the carrier (A) for essential oils is arranged between the low-frequency wave transmitter (2) and the low-frequency waveguide; wherein the low-frequency wave transmitter (2) can radiate a low-frequency wave (W) of a predetermined frequency; and wherein the low-frequency wave (W) can be transferred to the low-frequency waveguide after passing through the carrier (A) for essential oils, and wherein the energy of the low-frequency wave (W) can be radiated in a concentrated manner onto the low-frequency waveguide. [2] Healthcare device according to claim 1, characterized by that the carrier (A) for essential oils contains an essential oil. [3] Healthcare device according to claim 2, characterized bythat the carrier (A) for essential oils is selected from a group comprising a part of the plant containing the essential oil, a container in which the essential oil is stored, and an adsorbent material on which the essential oil is adsorbed. [4] Healthcare device according to claim 3, characterized by that the predetermined frequency is in the range of 1.27 to 1.81 Hz. [5] Healthcare device according to claim 4, characterized by that the low-frequency waveguide has a cylinder (3) and / or a cone (4) which is provided with a receiving space (331) in which the carrier (A) for essential oils is located. [6] Healthcare device according to claim 5, characterized byin that the healthcare device (100) is attached to a support bracket (200) and is located in a predetermined position (P) in front of the navel (11) of a user (1), wherein there is a predetermined distance (D) between the healthcare device and the navel, which distance is in the range of 5 to 8 centimeters. [7] Healthcare device according to claim 6, characterized by that the low-frequency waveguide is located at the predetermined position (P). [8] Healthcare device according to claim 7, characterized by that after the energy of the low frequency wave (W) is concentrated in the low frequency waveguide, it is radiated towards the navel and finally reaches the navel.

Images